Cargando…
Rhinovirus-16 increases ATP release in A549 cells without concomitant increase in production
Human rhinovirus (RV) is the most common cause of upper respiratory tract infection (URTI) and chronic airway disease exacerbation. Cough is present in 50–80% of URTI cases, accompanied by heightened airway hypersensitivity, yet no effective treatment currently exists for this infectious cough. The...
Autores principales: | Atkinson, Samantha K., Morice, Alyn H., Sadofsky, Laura R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569158/ https://www.ncbi.nlm.nih.gov/pubmed/33123553 http://dx.doi.org/10.1183/23120541.00159-2020 |
Ejemplares similares
-
Ingredients of Vicks VapoRub inhibit rhinovirus-induced ATP release
por: Stinson, Rebecca J, et al.
Publicado: (2023) -
How does rhinovirus cause the common cold cough?
por: Atkinson, Samantha K, et al.
Publicado: (2016) -
ATP, an attractive target for the treatment of refractory chronic cough
por: Zhang, Mengru, et al.
Publicado: (2022) -
Human TRPM8 and TRPA1 pain channels, including a gene variant with increased sensitivity to agonists (TRPA1 R797T), exhibit differential regulation by SRC-tyrosine kinase inhibitor
por: Morgan, Kevin, et al.
Publicado: (2014) -
Genetic variants affecting human TRPA1 or TRPM8 structure can be classified in vitro as ‘well expressed’, ‘poorly expressed’ or ‘salvageable’
por: Morgan, Kevin, et al.
Publicado: (2015)